An Internal Advisory Committee will be charged with monitoring the progress of the PJIs, selecting new PJIs for second phase participation, and advising the PI on COBRE development. Many committee members are past or current COBRE PIs. The duties of the Internal Advisory Committee include:
Joseph J. Ferretti, PhD
Former OUHSC Provost
Professor, Microbiology & Immunology
OUHSC, Oklahoma City, OK
James Tomasek, PhD
Vice President for Research
OUHSC, Oklahoma City, OK
John J. Iandolo, PhD
Vice President for Research (Retired)
OUHSC, Oklahoma City, OK
Judith A. James, MD, PhD
Member and Program Chair
Arthritis & Clinical Immunology Program
Oklahoma Medical Research Foundation, Oklahoma City, OK
Rodger P. McEver, MD
Member and Program Chair
Cardiovascular Biology Research Program
Oklahoma Medical Research Foundation, Oklahoma City, OK
Robert E. Anderson, MD, PhD
Director of Research
Dean A. McGee Eye Institute, Oklahoma City, OK
Jian-Xing Ma, MD, PhD
Chair, Department of Physiology
College of Medicine
OUHSC, Oklahoma City, OK
Darrin R. Akins, PhD
Associate Dean for Research
College of Medicine
OUHSC, Oklahoma City, OK
An External Advisory Committee, consisting of five nationally recognized cancer scientists, will meet with the PI, the Internal Advisory Committee, and the PJIs twice a year, monitoring the progress of their projects as well as the overall progress of the COBRE.
These researchers will meet with the COBRE investigators twice per year:
once in the fall in Oklahoma and once in the spring during the annual
meeting of the American Association for Cancer Research.
The proposed External Advisory Committee of the COBRE will have the following
responsibilities:
Channing J. Der, PhD
Professor, Department of Pharmacology Director, NIH Cancer Cell Biology Training
Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill, NC
J. Silvio Gutkind, PhD
Chief, Oral and Pharyngeal Cancer Branch
NIDCR
National Institutes of Health
Jennifer Grandis, MD
Program Leader, Head & Neck Cancer Program
University of Pittsburgh Cancer Institute
Gordon Mills, MD, PhD
Professor of Medicine, Olga Keith Wiess Distinguished University Chair
for Cancer Research
Chair, Department of Systems Biology
Head, Kleberg Center for Molecular Markers
M.D. Anderson Cancer Center, Houston, TX
Premkumar Reddy, PhD
Professor and Director Experimental Therapeutics Institute
Mount Sinai School of Medicine, NY
OU Health has opened the first clinic of its kind in Oklahoma to offer centralized, multidisciplinary care for adult patients with spina bifida, ...
The privacy and security of protected health information is of the utmost importance to OU Medicine, Inc. d/b/a OU Health (“OU Health”). This notice ...
OU Health is the first and only health system in Oklahoma to offer an incisionless treatment for patients with medical refractory essential tremor ...